Date Filed | Type | Description |
08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
05/31/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/23/2023 |
SC 13D
| Black Robe Capital LLC reports a 15.7% stake in INHIBITOR THERAPUTICS, INC. |
05/23/2023 |
SC 13G
| TPB 2012 LLC reports a 16.4% stake in Inhibitor Therapeutics, Inc. |
05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
12/19/2022 |
8-K
| Quarterly results |
11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
09/15/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
08/12/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
06/03/2022 |
8-K
| Quarterly results |
05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
03/30/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
01/18/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
11/12/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
08/13/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
05/14/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
03/26/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
01/06/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
12/17/2020 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
11/16/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
09/23/2020 |
8-K
| Quarterly results |
08/12/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
06/30/2020 |
8-K
| Quarterly results |
06/08/2020 |
8-K
| Other Events |
05/06/2020 |
8-K
| Quarterly results |
05/01/2020 |
10-Q
| Quarterly Report for the period ended March 31, 2020 |
04/16/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
03/30/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
02/10/2020 |
5
| Watson W. Mark (Director) has filed a Form 5 on Inhibitor Therapeutics, Inc. |
01/03/2020 |
8-K
| Quarterly results |
12/05/2019 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
11/07/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
10/31/2019 |
8-K
| Quarterly results |
|